BTRC and meningioma: The results show that the expression of β‐TrCP decreases in NF2‐associated meningioma cells after treatment with rapamycin (2 μmol/L 48 h), suggesting that the stability of PDL1 can also be regulated by inhibiting the mTOR pathway.